1241 |
The Benefit of High Intensity Atorvastatin/Ezetimine Combination Therapy in Coronary Risk Patients with Hypercholesterolemia |
Young-Hoon Jeong |
Apr. 12. 21 |
1240 |
Is Combination Therapy Recommended for All High Risk Patients : When and Why Combination Therapy Is Needed? |
Hyuck Jun Yoon |
Apr. 12. 21 |
1239 |
Lower Is Better & Combination Is Better |
Soe-Hee Ann |
Apr. 12. 21 |
1238 |
Double Prevention of CVD Risk for Hypertensive Patients by Polypill |
Jin-Man Cho |
Apr. 12. 21 |
1237 |
DES vs. DEB for ISR PCI - What Is the Best Weapon? |
Robert A. Byrne |
Apr. 12. 21 |
1236 |
Drug Coated Balloons: Present Status and Future of the Technology |
Aloke V. Finn |
Apr. 12. 21 |
1235 |
Orbital or Laser Atherectomy in Complex PCI |
Kevin Croce |
Apr. 12. 21 |
1234 |
What Is Complex PCI, Do Outcomes Depend on Complexity Type and Number? |
Mamas Mamas |
Apr. 12. 21 |
1233 |
Vulnerable Plaque: What Is It? Pathological Perspective |
Renu Virmani |
Apr. 12. 21 |
1232 |
Choice of PCI vs. CABG When Revascularization Is Indicated for LM Disease: CABG Preferred |
David Paul Taggart |
Apr. 12. 21 |